Splenectomy and surgical cytoreduction for ovarian cancer

Gynecologic Oncology

Volumn 77, Issue 3, 2000, Pages 362-368

  Chen, Lee May ^a   Leuchter, Ronald S ^a   Lagasse, Leo D ^a   Karlan, Beth Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytoreduction; Ovarian cancer; Recurrence; Splenectomy; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; MORBIDITY; OVARY CANCER; PRIORITY JOURNAL; SPLENECTOMY; SURGICAL TECHNIQUE; SURVIVAL TIME;

EID: 0034089495     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5800     Document Type: Article

References (14)

1. Bristow R E, Lagasse L D, Karlan B Y. Secondary surgical cytoreduction for advanced epithelial ovarian cancer: patient selection and review of the literature. Cancer. 78:1996;2049-2062.
2. Janicke F, Holscher M, Kuhn W, von Hugo R, Pache L, Siewert J R, Graeff H. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer. 70:1992;2129-2136.
3. Farias-Eisner R, Braly P, Berek J S. Solitary recurrent metastasis of epithelial ovarian cancer in the spleen. Gynecol Oncol. 48:1993;338-341.
4. Nelson B E, Rose P G, Reale F R. Isolated parenchymal splenic metastasis in epithelial ovarian cancer. Gynecol Oncol. 50:1993;124-127.
5. Balat O, Verschraeger C, Erbilen M, Edwards C L, Silva E, Kudelka A P, Kavanagh J J. Recurrence of ovarian cancer as a delayed solitary parenchymal splenic metastasis. Int J Gynecol Cancer. 6:1996;496-498.
6. Morris M, Gershenson D M, Burke T W, Wharton J T, Copeland L J, Rutledge F N. Splenectomy in gynecologic oncology: indications, complications, and technique. Gynecol Oncol. 43:1991;119-122.
7. Berek J S, Hacker N F, Lagasse L D, Nieberg R K, Elashoff R M. Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol. 61:1983;189-193.
8. Vaccarello L, Rubin S C, Vlamis V, Wong G, Jones W B, Lewis J L, Hoskins W J. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol. 57:1995;61-65.
9. Malfetano J H. Splenectomy for optimal cytoreduction in ovarian cancer. Gynecol Oncol. 24:1986;392-394.
10. Sonnendecker E WW, Guidozzi F, Marglius K A. Splenectomy during primary maximal cytoreductive surgery for epithelial ovarian cancer. Gynecol Oncol. 35:1989;301-306.
11. Kuhn W, Florack G, Roder J, Schmalfeldt B, Pache L, Rust M, Ulm K, Spathe K, Janicke F, Siewert J R, Graeff H. The influence of upper abdominal surgery on perioperative morbidity and mortality in patients with advanced ovarian cancer FIGO III and FIGO IV. Int J Gynecol Cancer. 8:1998;56-63.
12. Nicklin J L, Copeland L J, O'Toole R V, Lewandowski G S, Vaccarello L, Havenar L P. Splenectomy as part of cytoreductive surgery for ovarian carcinoma. Gynecol Oncol. 58:1995;244-247.
13. Scarabelli C, Gallo A, Campagnutta E, Carbone A. Splenectomy during primary and secondary cytoreductive surgery for epithelial ovarian carcinoma. Int J Gynecol Cancer. 8:1998;215-221.
14. Gemingnani, ML, Chi D S, Gurin C C, Curtin, Barakat R R. Splenectomy in recurrent epithelial ovarian cancer. Gynecol Oncol. 72:1999;407-410.